Ingersoll Rand market cap is $23.7 b, and annual revenue was $2.45 b in FY 2019

Ingersoll Rand Gross profit (Q1, 2020)244.5 M

Ingersoll Rand Gross profit margin (Q1, 2020), %30.6%

Ingersoll Rand Net income (Q1, 2020)-36.8 M

Ingersoll Rand EBIT (Q1, 2020)-66.8 M

Ingersoll Rand Cash, 31-Mar-2020555.7 M

Ingersoll Rand EV26.6 B

Ingersoll Rand revenue was $2.45 b in FY, 2019 which is a 8.8% year over year decrease from the previous period.

Ingersoll Rand revenue breakdown by business segment: 53.1% from Industrials, 35.5% from Energy and 11.4% from Medical

Ingersoll Rand revenue breakdown by geographic segment: 15.3% from Asia Pacific, 40.7% from United States, 7.7% from Other Americas and 36.3% from EMEA

USD | FY, 2017 | FY, 2018 | FY, 2019 |
---|---|---|---|

## Revenue | 2.4b | 2.7b | 2.5b |

| 22% | 13% | (9%) |

## Cost of goods sold | 1.5b | 1.7b | 1.5b |

## Gross profit | 897.9m | 1.0b | 911.7m |

| 38% | 38% | 37% |

## General and administrative expense | 446.6m | 434.6m | 436.4m |

## Operating expense total | 789.2m | 569.5m | 636.4m |

## Depreciation and amortization | 118.9m | 125.8m | 124.3m |

## EBIT | 108.7m | 443.0m | 275.3m |

| 5% | 16% | 11% |

## Interest expense | 140.7m | 99.6m | 88.9m |

## Pre tax profit | (112.7m) | 349.5m | 190.9m |

## Income tax expense | (131.2m) | 80.1m | 31.8m |

## Net Income | 18.5m | 269.4m | 159.1m |

## EPS | 0.1 | 1.3 | 0.8 |

USD | Q2, 2017 | Q3, 2017 | Q1, 2018 | Q2, 2018 | Q3, 2018 | Q1, 2019 | Q2, 2019 | Q3, 2019 | Q1, 2020 |
---|---|---|---|---|---|---|---|---|---|

## Revenue | 579.1m | 649.6m | 619.6m | 668.2m | 689.3m | 620.3m | 629.1m | 596.7m | 799.9m |

## Cost of goods sold | 363.2m | 395.7m | 387.7m | 418.9m | 426.9m | 389.8m | 394.7m | 375.2m | 555.4m |

## Gross profit | 215.9m | 253.9m | 231.9m | 249.3m | 262.4m | 230.5m | 234.4m | 221.5m | 244.5m |

| 37% | 39% | 37% | 37% | 38% | 37% | 37% | 37% | 31% |

## General and administrative expense | 125.6m | 111.1m | 106.9m | 115.8m | 107.7m | 107.7m | 103.6m | 95.3m | 155.4m |

## Operating expense total | 317.5m | 158.0m | 142.1m | 147.9m | 144.7m | 150.3m | 159.8m | 148.6m | 311.3m |

## Depreciation and amortization | 30.5m | 29.5m | 30.9m | 31.5m | 31.0m | 31.4m | 30.9m | 30.4m | 55.2m |

## EBIT | (101.6m) | 95.9m | 89.8m | 101.4m | 117.7m | 80.2m | 74.6m | 72.9m | (66.8m) |

| (18%) | 15% | 14% | 15% | 17% | 13% | 12% | 12% | (8%) |

## Interest expense | 39.5m | 30.1m | 26.0m | 26.1m | 24.4m | 22.4m | 22.4m | 23.2m | 27.1m |

## Pre tax profit | (190.2m) | 32.4m | 65.8m | 77.5m | 94.8m | 59.1m | 53.2m | 50.3m | (95.7m) |

## Income tax expense | (43.9m) | 4.4m | 23.4m | 17.2m | 22.6m | 12.0m | 8.3m | 9.0m | (58.9m) |

## Net Income | (146.3m) | 28.0m | 42.4m | 60.3m | 72.2m | 47.1m | 44.9m | 41.3m | (36.8m) |

## EPS | (0.8) | 0.1 | 0.2 | 0.3 | 0.4 | 0.2 | 0.2 | 0.2 | (0.1) |

USD | FY, 2017 | FY, 2018 | FY, 2019 |
---|---|---|---|

## Cash | 393.3m | 221.2m | 505.5m |

## Accounts Receivable | 536.3m | 525.4m | 459.1m |

## Inventories | 494.5m | 523.9m | 502.5m |

## Current Assets | 1.5b | 1.3b | 1.5b |

## PP&E | 363.2m | 356.6m | 326.6m |

## Goodwill | 1.2b | 1.3b | 1.3b |

## Total Assets | 4.6b | 4.5b | 4.6b |

## Accounts Payable | 269.7m | 340.0m | 322.9m |

## Short-term debt | 20.9m | 7.9m | 7.6m |

## Current Liabilities | 561.8m | 596.4m | 574.6m |

## Long-term debt | 2.0b | 1.7b | 1.6b |

## Total Debt | 2.0b | 1.7b | 1.6b |

## Total Liabilities | 3.1b | 2.8b | 2.8b |

## Common Stock | 2.0m | 2.0m | 2.1m |

## Additional Paid-in Capital | 2.3b | 2.3b | 2.3b |

## Retained Earnings | (577.8m) | (308.7m) | (141.4m) |

## Total Equity | 1.5b | 1.7b | 1.9b |

## Debt to Equity Ratio | 1.4 x | 1 x | 0.9 x |

## Debt to Assets Ratio | 0.4 x | 0.4 x | 0.3 x |

## Financial Leverage | 3.1 x | 2.7 x | 2.5 x |

USD | FY, 2017 | FY, 2018 | FY, 2019 |
---|---|---|---|

## Net Income | 18.5m | 269.4m | 159.1m |

## Depreciation and Amortization | 175.4m | 180.4m | 178.1m |

## Accounts Receivable | (65.7m) | 13.2m | 54.7m |

## Inventories | (22.7m) | (13.0m) | 18.7m |

## Accounts Payable | 39.9m | 69.6m | (9.2m) |

## Cash From Operating Activities | 200.5m | 444.5m | 343.3m |

## Capital Expenditures | (56.8m) | (52.2m) | (43.2m) |

## Cash From Investing Activities | (60.8m) | (235.0m) | (54.3m) |

## Long-term Borrowings | (2.9b) | (337.6m) | (32.8m) |

## Cash From Financing Activities | (17.4m) | (373.0m) | (11.5m) |

## Net Change in Cash | 137.5m | (172.1m) | 284.3m |

## Interest Paid | 142.5m | 98.5m | 85.6m |

## Income Taxes Paid | 55.5m | 103.1m | 61.6m |

## Free Cash Flow | 143.7m | 392.3m | 300.1m |

USD | Q2, 2017 |
---|---|

## Debt/Equity | 1.6 x |

## Debt/Assets | 0.4 x |

## Financial Leverage | 3.7 x |

Q3, 2017 | Q4, 2017 | FY, 2017 | Q1, 2018 | Q2, 2018 | Q3, 2018 | Q4, 2018 | FY, 2018 | Q1, 2019 | Q2, 2019 | Q3, 2019 | Q4, 2019 | FY, 2019 | Q1, 2020 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|

## Order Volume (Industrial) | $294.4 m | $319.2 m | $337.8 m | $336.2 m | $313.4 m | $322.5 m | $334.6 m | $323.2 m | $313.1 m | $307.6 m | ||||

## Order Volume (Energy) | $251.1 m | $281.2 m | $291 m | $303.7 m | $260.6 m | $269.5 m | $208.2 m | $207.1 m | $205 m | $171.8 m | ||||

## Order Volume (Medical) | $61.1 m | $66.8 m | $75 m | $72.5 m | $73.5 m | $65.8 m | $71 m | $76.4 m | $66.5 m | $63.7 m | ||||

## Order Volume (Industrial Technologies and Services) | $567.5 m | |||||||||||||

## Order Volume (Precision and Science Technologies) | $130.8 m | |||||||||||||

## Order Volume (High Pressure Solutions) | $83.5 m | |||||||||||||

## Order Volume (Specialty Vehicle Technologies) | $62.4 m | |||||||||||||

## Countries | 175 | 175 | 175 | |||||||||||

## Distributors | 1 k | 1 k | 1 k | |||||||||||

## Manufacturing Facilities | 38 | 41 | 38 | |||||||||||

## Manufacturing Facilities (Americas) | 16 | 18 | 16 | |||||||||||

## Manufacturing Facilities (Asia Pacific) | 4 | 4 | 3 | |||||||||||

## Manufacturing Facilities (EMEA) | 18 | 19 | 19 | |||||||||||

## Manufacturing Facilities (Energy) | 15 | 15 | 14 | |||||||||||

## Manufacturing Facilities (Energy, APAC) | 2 | 2 | 2 | |||||||||||

## Manufacturing Facilities (Energy, Americas) | 8 | 8 | 7 | |||||||||||

## Manufacturing Facilities (Energy, EMEA) | 5 | 5 | 5 | |||||||||||

## Manufacturing Facilities (Industrials) | 15 | 18 | 16 | |||||||||||

## Manufacturing Facilities (Industrials, APAC) | 1 | 1 | ||||||||||||

## Manufacturing Facilities (Industrials, Americas) | 5 | 7 | 6 | |||||||||||

## Manufacturing Facilities (Industrials, EMEA) | 9 | 10 | 10 | |||||||||||

## Manufacturing Facilities (Medical) | 8 | 8 | 8 | |||||||||||

## Manufacturing Facilities (Medical, APAC) | 1 | 1 | 1 | |||||||||||

## Manufacturing Facilities (Medical, Americas) | 3 | 3 | 3 | |||||||||||

## Manufacturing Facilities (Medical, EMEA) | 4 | 4 | 4 | |||||||||||

## Patents | 570 | 610 | 600 | |||||||||||

## Service Centers | 30 | 30 | 30 | |||||||||||

## Warehouses | 5 | 6 | 4 | |||||||||||

## Warehouses (APAC) | 1 | 1 | 1 | |||||||||||

## Warehouses (Americas) | 3 | 4 | 2 | |||||||||||

## Warehouses (EMEA) | 1 | 1 | 1 | |||||||||||

## Warehouses (Energy) | 2 | 3 | 1 | |||||||||||

## Warehouses (Energy, Americas) | 2 | 3 | 1 | |||||||||||

## Warehouses (Industrials) | 3 | 3 | 3 | |||||||||||

## Warehouses (Industrials, APAC) | 1 | 1 | 1 | |||||||||||

## Warehouses (Industrials, Americas) | 1 | 1 | 1 | |||||||||||

## Warehouses (Industrials, EMEA) | 1 | 1 | 1 |